CHRISTOPHER A. WILLIAMS

Of Counsel
Antitrust

EXPERIENCE:

Chris Williams is Of Counsel in the Washington, D.C., office of Wilson Sonsini Goodrich & Rosati, where he is a member of the firm's antitrust and national security practices. His antitrust experience includes merger notification and clearance, civil and criminal litigation, government investigations, and business counseling. He has represented clients in a wide range of industries, including information technology, electronics and computer hardware, semiconductors, telecommunications, healthcare, life sciences, pharmaceuticals, chemicals, and energy and utilities.

Prior to joining the firm, Chris was an associate in the Washington, D.C., office of an international law firm, where he practiced antitrust, international trade, export controls and economic sanctions, and foreign investment law.

EDUCATION:
  • J.D., American University Washington College of Law, 2008
    Cum Laude; Staff, Administrative Law Review
  • B.S., Economics, Duke University, 2004
    Cum Laude; Second Major in Public Policy Studies; Minor in Political Science; NCAA Division I Men's Cross Country Academic All-American, 2001 and 2002
HONORS:
  • Named to the 2014, 2015, 2016, and 2017 "Rising Stars" lists published by Washington DC Super Lawyers
SELECT PUBLICATIONS:
  • Co-author with P.S. Jin and R.E. Comerford, "U.S." chapter, Merger Control, Sixth Edition, Global Legal Insights, 2017
  • Co-author with S.A. Sher and T.V. Hoang, "Narrowing the Investment-Only Exemption: An Examination of ValueAct and Where to Go from Here," The Exchange, American Bar Association Section of Antitrust Law, Insurance and Financial Services Committee Newsletter, Fall 2016
  • Co-author with S. Sher and B. Tennis, "U.S. Antitrust" chapter, The Mergers & Acquisitions Review, Ninth Edition, Law Business Research, 2015
  • Co-author with P.S. Jin, "U.S." chapter, Merger Control, Fourth Edition, Global Legal Insights, 2015
  • Co-author with M. Rosman and J. VanHooreweghe, "U.S." chapter, Cartels, Third Edition, Global Legal Insights, 2015
  • Co-author with S. Sher, "Rethinking the Investment-Only Exemption," The Threshold, Vol. XV, No. 1, Fall 2014
  • Co-author with Scott A. Sher and Bradley T. Tennis of "US Antitrust" chapter, The Mergers & Acquisitions Review, Eighth Edition, Law Business Research, 2014
  • Co-author with C. Biggio, P. Jin, A. Murino, and S. Silber, "District Court Upholds HSR Rulemaking on Pharmaceutical Patent Licensing Transactions," WSGR Alert, June 2, 2014
  • Co-author with P. Jin and S. Silber, "FTC Expands the Scope of Pharmaceutical Licensing Transactions That Will Be Subject to Premerger Review," WSGR Alert, November 12, 2013
  • Co-author of "US Antitrust" chapter, The Mergers & Acquisitions Review, Seventh Edition, Law Business Research, 2013
  • Co-author of "US Antitrust" chapter, The Mergers & Acquisitions Review, Sixth Edition, Law Business Research, 2012
  • Contributor, Annual Review of Antitrust Law Developments, 2012, 2013
  • Co-author with Barry A. Pupkin, "Antitrust Leniency Programs in Latin America: Part II," Latin American Law & Business Report, Vol. 18, No. 7, July 2010
  • Co-author with Barry A. Pupkin, "Antitrust Leniency Programs in Latin America: Part I," Latin American Law & Business Report, Vol. 18, No. 6, June 2010
SELECT SPEAKING ENGAGEMENTS:
  • Speaker, "Patent Acquisitions—When Are They HSR Reportable?" The Knowledge Group, Webinar, April 9, 2014
  • Panelist, "Recent Antitrust Developments in the Health Care and Pharmaceuticals Markets: October and November 2012," ABA Section of Antitrust Law program, Washington, D.C., December 6, 2012
  • Moderator, "Working with Economic Experts in Section 1 Cases," ABA Section of Antitrust Law program, Washington, D.C., July 28, 2011
ADMISSIONS:
  • Bar of the District of Columbia
  • State Bar of Florida
  • U.S. Court of Appeals for the Federal Circuit
  • U.S. Court of International Trade